Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
基本信息
- 批准号:10017683
- 负责人:
- 金额:$ 46.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAdultAffectAwardBehavioralBody Weight decreasedCellular PhoneCenters for Disease Control and Prevention (U.S.)CommunicationComputersDataDiabetes preventionDimensionsEffectivenessEmployeeEnrollmentEvaluationEvaluation ResearchFeedbackGoalsGroup StructureHealthHealth PromotionHealthcareIncentivesInsurance CarriersInterviewLocationMethodsModalityModelingMotivationObesityOutcomeParticipantPersonsPoliciesPopulationProductivityProgram EvaluationPublic HealthResearchSocial supportSourceSubgroupTabletsTeleconferencesTestingTimeUnited States Centers for Medicare and Medicaid ServicesUniversitiesWeightWeight maintenance regimenWellness ProgramWorkplacebasecompare effectivenesscostdiabetes prevention programevaluation/testingevidence basefinancial incentiveimplementation strategyimprovedpreventprimary outcomeprogramsskillstelehealthvirtual
项目摘要
PROJECT SUMMARY
More than 60 employers and insurers now offer the Centers for Disease Control and Prevention (CDC)
National Diabetes Prevention Program (DPP) as an evidence-based weight management program for
employees. Health Plus, the workplace wellness division of Vanderbilt Health and Wellness, began offering the
DPP in 2014 as a benefit to the approximately 25,000 employees of Vanderbilt University (VU) and Vanderbilt
University Medical Center (VUMC). The goal of the DPP is for participants to lose 5% of their baseline weight
by the end of the year-long program. From 2014-2017, the proportion of Health Plus DPP (HP-DPP)
participants achieving this goal exceeded National DPP metrics (43.6% of HP-DPP participants versus 35.5%
of DPP participants nationwide) and the program earned full recognition status from the CDC Diabetes
Prevention Recognition Program. Yet comparisons of potential and actual participation in the HP-DPP suggest
many employees likely to benefit from this highly effective program are not participating in it. Program reach is
often limited for both worksite wellness programs and DPPs because of inconvenient locations, time
limitations, insufficient incentives, and confidentiality concerns. Feedback collected from HP-DPP participants
from 2014-2017 suggests the need to meet in person on the VU/VUMC main campus to participate in the
program was a key barrier to its reach during this interval. However, the group structure of the program was
noted to be a key source of support and motivation. To improve the reach of the highly effective HP-DPP while
maintaining the benefits of its group structure, the HP-DPP introduced a video-teleconference (VTC) group
(telehealth) participation option in 2018. Although the CDC endorses the use of telehealth as a DPP
implementation strategy, few studies have compared the effectiveness of telehealth and in-person delivery
platforms for achieving weight loss. No studies have compared weight loss outcomes for VTC and in-person
DPP groups in which the VTC group participates solely via online interactions. The Centers for Medicare and
Medicaid Services (CMS) recently decided not to reimburse DPPs utilizing a telehealth platform for program
delivery without further testing and evaluation of virtual DPPs. Thus, the need for research to guide the use of
telehealth as a DPP implementation strategy is relevant at both a local and national level. This project will
evaluate the HP-DPP in terms of the reach, effectiveness, and implementation dimensions of the RE-AIM
model by (1) comparing the reach, effectiveness, and implementation of the HP-DPP before versus after the
introduction of the VTC participation option, (2) comparing the effectiveness and implementation of VTC versus
in-person HP-DPP groups in the “after” period, and (3) exploring reasons for differences in the reach,
effectiveness, and/or implementation of the HP-DPP that are associated with inclusion of the VTC participation
option using in-depth interviews. The results of this evaluation will directly inform efforts to extend the reach
and public health impact of DPPs both within and beyond worksites.
项目概要
现在有 60 多家雇主和保险公司提供疾病控制和预防中心 (CDC) 服务
国家糖尿病预防计划 (DPP) 作为一项基于证据的体重管理计划
雇员。范德比尔特健康与保健公司 (Vanderbilt Health and Wellness) 的工作场所健康部门 Health Plus 开始提供
2014 年 DPP 为范德比尔特大学 (VU) 和范德比尔特大学约 25,000 名员工提供福利
大学医学中心(VUMC)。 DPP 的目标是让参与者减掉基线体重的 5%
在为期一年的计划结束时。 2014-2017年Health Plus DPP(HP-DPP)比例
实现这一目标的参与者超过了国家 DPP 指标(HP-DPP 参与者为 43.6%,而 35.5%
全国 DPP 参与者),该计划获得了 CDC 糖尿病中心的充分认可
预防认可计划。然而,对 HP-DPP 的潜在参与和实际参与的比较表明
许多可能从这一高效计划中受益的员工却没有参与其中。计划范围是
由于地点、时间不方便,工作场所健康计划和 DPP 往往受到限制
限制、激励不足和保密问题。从 HP-DPP 参与者收集的反馈
2014-2017 年建议需要亲自在 VU/VUMC 主校区见面以参加
在此期间,该计划是其影响力的主要障碍。然而,该计划的小组结构是
被认为是支持和动力的关键来源。提高高效 HP-DPP 的覆盖范围,同时
为了保持其小组结构的优势,HP-DPP 引入了视频电话会议 (VTC) 小组
2018 年的(远程医疗)参与选项。尽管 CDC 认可使用远程医疗作为 DPP
实施策略,很少有研究比较远程医疗和面对面交付的有效性
实现减肥的平台。没有研究比较 VTC 和面对面的减肥效果
VTC 小组仅通过在线互动参与的 DPP 小组。医疗保险中心和
医疗补助服务 (CMS) 最近决定不向使用远程医疗平台计划的 DPP 进行报销
无需对虚拟 DPP 进行进一步测试和评估即可交付。因此,需要进行研究来指导使用
远程医疗作为 DPP 实施战略在地方和国家层面都具有相关性。该项目将
从 RE-AIM 的范围、有效性和实施维度评估 HP-DPP
通过 (1) 比较 HP-DPP 实施前后的范围、有效性和实施情况来建立模型
引入 VTC 参与选项,(2) 比较 VTC 与 VTC 的有效性和实施情况
“之后”时期的面对面 HP-DPP 小组,以及 (3) 探讨影响范围差异的原因,
与 VTC 参与相关的 HP-DPP 的有效性和/或实施
使用深度访谈的选项。此次评估的结果将直接为扩大覆盖范围的努力提供信息
以及 DPP 对工作场所内外的公共卫生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rosette J Chakkalakal其他文献
Capsule Commentary on Pilla et al., Predictors of Insulin Initiation in Patients with Type 2 Diabetes: an Analysis of the Look AHEAD Randomized Trial
Pilla 等人的胶囊评论,2 型糖尿病患者胰岛素起始的预测因素:Look AHEAD 随机试验的分析
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:5.7
- 作者:
Rosette J Chakkalakal - 通讯作者:
Rosette J Chakkalakal
Hospitalization Rates for Acute Myocardial Infarction Among Asian-American Subgroups: Have We Been Underestimating the Problem?
亚裔美国人亚群体急性心肌梗死的住院率:我们是否低估了这个问题?
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:1.9
- 作者:
Rosette J Chakkalakal;J. Fox;J. Green;M. Nunez;B. Nallamothu;R. Hasnain - 通讯作者:
R. Hasnain
1643-P: Prevalence of Diabetes Medication Regimens in PCORnet, the National Patient-Centered Clinical Research Network
1643-P:PCORnet(国家以患者为中心的临床研究网络)中糖尿病药物治疗方案的流行率
- DOI:
10.2337/db19-1643-p - 发表时间:
2019 - 期刊:
- 影响因子:7.7
- 作者:
Katherine N. Bachmann;C. Roumie;Andrew D. Wiese;Carlos G. Grijalva;J. Buse;Robert L. Bradford;Emily Zalimeni;Patricia Knoepp;H. Morris;W. Donahoo;Nada Fanous;V. Fonseca;Bonnie L Katalenich;M. Cook;R. Rothman;Rosette J Chakkalakal - 通讯作者:
Rosette J Chakkalakal
Rosette J Chakkalakal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rosette J Chakkalakal', 18)}}的其他基金
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10456167 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10632758 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10669641 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10597811 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
测试远程医疗:评估使用远程医疗来增加基于雇主的糖尿病预防计划的人群影响
- 批准号:
10254280 - 财政年份:2019
- 资助金额:
$ 46.43万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Research Grant